ArticleMedicina (Kaunas, Lithuania)2024

Combining Endocrine Therapy with Trastuzumab Emtansine Improves Progression-Free Survival and Overall Survival in HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer.

Oğuzcan Kınıkoğlu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.